MicroPort Orthopedics Complete Profemur Gladiator Hip System Now Available

CathWorks FFRangio™ System Receives National Reimbursement Approval in Japan

CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the application to provide reimbursement for the CathWorks FFRangio™ System,...

Levine Leichtman Capital Partners Sells FlexXray

Levine Leichtman Capital Partners ("LLCP"), a Los Angeles-based private equity firm, announced today that it has sold its portfolio company FlexXray Holdings, LLC ("FlexXray" or...

February 18, 2021

MicroPort Orthopedics announced the availability of its Profemur® Gladiator® HA Collared Stem and Profemur® Gladiator® Cemented Collared Stem.

Combined with its current Profemur® Gladiator® Plasma Stem, the Gladiator® Hip Stem System is now complete, offering  a wide range of indications in the treatment of both high demand total hip arthroplasties and low demand fracture patients.
Designed for primary hip replacement surgery, the Profemur® Gladiator® Hip Stems all offer a triple wedge tapered design with distinct geometry. The hip stem is designed with a reduced lateral shoulder convenient for tissue-sparing techniques, making it perfectly suited to be used with MicroPort’s disruptive innovation through the Anterior Path® surgical approach.  The Profemur® line of Hip Stems gives surgeons the versatility to address their patients’ needs with one set of instruments in this truly comprehensive system.
“By allowing surgeons to cater a femoral hip system to their preferred techniques, we have created a customizable hip system that is Simply Versatile™ in its ability to exceed the needs of each surgeon, designed to help our surgeons more effectively treat patients,” said Benny Hagag, President of MicroPort Orthopedics. “This customization to tissue-sparing techniques allows for streamlined preoperative planning, excellent patient outcomes1,2, and a quicker recovery3. The proof is in our patients.”
spot_img

DON'T MISS

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.